Document Detail


Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications.
MedLine Citation:
PMID:  12366619     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine the association between angiotensin-converting enzyme (ACE) inhibitor therapy and survival of older heart failure patients with conditions perceived by physicians as contraindications to ACE inhibitors. SETTING: Hospital. DESIGN: Retrospective follow-up study. PARTICIPANTS: Hospitalized older heart failure patients with systolic blood pressure of 90 mmHg or less, serum creatinine of 2.5 mg/dL or more, serum potassium of 5.5 mmol/L or more, or severe aortic stenosis. MEASUREMENTS: One-year postdischarge mortality (with and without adjustment for various patient and care characteristics). Logistic regression analyses were used to estimate the effect of the perceived contraindications on subsequent use of ACE inhibitors. Using Cox proportional hazards models, crude and adjusted hazard ratios (HRs) of 1-year mortality with 95% confidence intervals (CIs) were estimated for patients discharged on ACE inhibitors and compared with those without. HRs were estimated for all patients and were repeated after stratifying patients based on the presence of perceived contraindications to ACE inhibitor use. RESULTS: Of the 295 subjects, 52 (18%) had conditions perceived as contraindications, 186 (63%) received ACE inhibitors, and 107 (40%) died within 1 year of discharge. Presence of a perceived contraindication was independently associated with underutilization of ACE inhibitors on discharge (adjusted OR = 0.35, 95% CI = 0.17-0.71). ACE inhibitor prescription at discharge was associated with lower 1-year mortality overall (HR = 0.58, 95% CI = 0.40-0.85) and for the groups of patients with (HR = 0.34, 95% CI = 0.14-0.81) and without (HR = 0.66, 95% CI = 0.42-1.02) perceived contraindications. CONCLUSIONS: ACE inhibitor use was associated with a significant survival benefit in this cohort of hospitalized older heart failure patients with perceived contraindications.
Authors:
Ali Ahmed; Catarina I Kiefe; Richard M Allman; Richard V Sims; James F DeLong
Related Documents :
21537649 - Systemic sclerosis-associated interstitial pneumonia: evaluation of pulmonary function ...
16964989 - Intravenous esmolol is well tolerated in elderly patients with heart failure in the ear...
15628109 - Cardiac resynchronization therapy in patients with heart failure and conduction abnorma...
18022259 - Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
8933239 - Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the cal...
16234899 - Chronic heart failure and multiple micronutrient supplementation: realistic hope or ide...
1541139 - Bradyarrhythmias incident to thrombolysis for acute inferior wall infarction. a caveat.
21245799 - B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
8938919 - Gender differences among civilly committed schizophrenia subjects.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of the American Geriatrics Society     Volume:  50     ISSN:  0002-8614     ISO Abbreviation:  J Am Geriatr Soc     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-10-07     Completed Date:  2002-12-19     Revised Date:  2008-03-10    
Medline Journal Info:
Nlm Unique ID:  7503062     Medline TA:  J Am Geriatr Soc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1659-66     Citation Subset:  IM    
Affiliation:
Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Alabama at Birmingham, USA. aahmed@uab.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors / contraindications,  therapeutic use*
Female
Follow-Up Studies
Heart Failure / drug therapy*,  mortality
Hospitalization
Humans
Male
Patient Discharge / statistics & numerical data
Proportional Hazards Models
Retrospective Studies
Survival Analysis
Survival Rate
Treatment Outcome
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of comorbid illness on receipt of cancer screening by older people.
Next Document:  Bloodstream infection: differences between young-old, old, and old-old patients.